You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oligoprogressive

Showing 1 - 25 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Oligoprogressive, Small-cell Lung Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 27, 2023

Oligoprogressive Trial (IMSA101, Immune checkpoint inhibitor, PULSAR)

Not yet recruiting
  • Oligoprogressive
  • (no location specified)
May 5, 2023

Primary Breast Oligoprogressive Sites Treated With Radiotherapy

Not yet recruiting
  • Breast Carcinoma
  • Non-Interventional Study
  • Scottsdale, Arizona
  • +2 more
Sep 26, 2023

Oligorecurrent and Oligoprogressive Prostate Cancer Patients Trial in Rozzano (procedure, drug, biological)

Recruiting
  • Oligorecurrent and Oligoprogressive Prostate Cancer Patients
  • Radiotherapy
  • +2 more
  • Rozzano, Milano, Italy
    Humanitas Research Hospital
May 3, 2022

Lung Adenocarcinoma, Lung Tumors Trial run by the NCI (osimertinib, LAT)

Completed
  • Lung Adenocarcinoma
  • Lung Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 17, 2022

NSCLC Stage IV Trial in Hangzhou (SBRT)

Recruiting
  • NSCLC Stage IV
  • SBRT
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 22, 2022

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Duarte, New Haven (procedure, drug, radiation, other)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +1 more
Aug 24, 2023

Lung Non-Small Cell Carcinoma, Malignant Solid Tumor, Melanoma Trial in Duarte (procedure, other, radiation)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Apr 13, 2023

Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)

Recruiting
  • Prostate Cancer
  • +3 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 19, 2023

Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Breast Cancer
  • +4 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 19, 2023

Oligoprogressive Renal Cell Carcinoma Trial in Dallas (Stereotactic ablative body radiation (SABR))

Active, not recruiting
  • Oligoprogressive Renal Cell Carcinoma
  • Stereotactic ablative body radiation (SABR)
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Nov 28, 2022

NSCLC Stage IV Trial in Bellinzona, Chur, Geneva (Atezolizumab)

Recruiting
  • NSCLC Stage IV
  • Bellinzona, Switzerland
  • +2 more
Apr 26, 2022

Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Esophageal Cancer
  • +10 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 27, 2023

Metastatic Renal Cell Carcinoma, Radiotherapy Trial in France (Steretactic radiotherapy, Pursuit of ongoing systemic treatment)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Radiotherapy
  • Steretactic radiotherapy
  • Pursuit of ongoing systemic treatment
  • Albi, France
  • +17 more
Aug 9, 2022

NSCLC With Mutation in Epidermal Growth Factor Receptor Trial in Leuven (Local ablative therapy)

Recruiting
  • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
  • Local ablative therapy
  • Leuven, Belgium
    UZLeuven
Oct 21, 2021

Metastatic Prostate Cancer, Castration-resistant Prostate Cancer Trial in Montréal (Darolutamide (BAY1841788), SBRT)

Recruiting
  • Metastatic Prostate Cancer
  • Castration-resistant Prostate Cancer
  • Darolutamide (BAY1841788)
  • SBRT
  • Montréal, Quebec, Canada
    Sir Mortimer JGH
Sep 20, 2021

Oligoprogressive, Castration-Resistant Prostate Cancer Trial in Toronto (Stereotactic Body Radiation Therapy (SABR))

Recruiting
  • Oligoprogressive
  • Castration-Resistant Prostate Cancer
  • Stereotactic Body Radiation Therapy (SABR)
  • Toronto, Ontario, Canada
    Odette Cancer Centre
Apr 9, 2021

Head Neck Cancer, Metastatic Cancer, Oligoprogressive Trial in Montréal (Standard arm, Experimental arm)

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Standard arm
  • Experimental arm
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal
Mar 6, 2022

Breast Cancer Invasive, Metastatic Cancer, Oligoprogressive Trial in Amsterdam (procedure, radiation, other)

Not yet recruiting
  • Breast Cancer Invasive
  • +2 more
  • Surgery
  • +2 more
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Mar 21, 2022

NSCLC Stage IV Trial in Shanghai (PD-1 Blockade, SBRT)

Recruiting
  • NSCLC Stage IV
  • PD-1 Blockade
  • SBRT
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 19, 2021

Oligometastatic Disease, Prostatic Cancer, Castration-Resistant Trial in Dresden (local ablative radiotherapy)

Recruiting
  • Oligometastatic Disease
  • Prostatic Cancer, Castration-Resistant
  • local ablative radiotherapy
  • Dresden, Saxony, Germany
    Department of Radiotherapy and Radiation Oncology, Faculty of Me
Aug 18, 2021

TNBC - Triple-Negative Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in United States (Sterotactic Body

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • +6 more
  • Sterotactic Body Radiotherapy/SBRT
  • Standard of care
  • Basking Ridge, New Jersey
  • +8 more
Jul 26, 2022

Pancreas Cancer, Lung Cancer, Renal Cancer Trial in Boston (MR-guided Linac)

Recruiting
  • Pancreas Cancer
  • +12 more
  • MR-guided Linac
  • Boston, Massachusetts
  • +1 more
Sep 21, 2021

NSCLC, Oligoprogressive Trial in Guangzhou (Furmonertinib)

Recruiting
  • Non-small Cell Lung Cancer
  • Oligoprogressive
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Jul 10, 2021

Stage III Lung Cancer AJCC v8, Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Cancer AJCC v8 Trial in Houston

Not yet recruiting
  • Stage III Lung Cancer AJCC v8
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
May 14, 2021